Gene therapy is revolutionizing treatment options for inherited skin disorders like epidermolysis bullosa. This session highlights breakthroughs in CRISPR-based editing, ethical considerations, and regulatory landscapes for genetic dermatologic therapies, pointing toward a personalized approach.